Results 211 to 220 of about 172,419 (302)

Chinese expert consensus on magnetic resonance-guided focused ultrasound surgery for painful bone metastases. [PDF]

Insights Imaging
Fan X, Tang N, Gu J, Yin X, Liu D, Shen J, Zhang J, Wang S, Wang H.   +8 more
europepmc   +1 more source

Hyperostosis frontalis interna: Observed patterns, prevalence, and dementia associations in older adults

The Anatomical Record, EarlyView.
Abstract Hyperostosis frontalis interna (HFI) is a frequently underrecognized condition characterized by overgrowth of the frontal endocranium, most commonly observed in post‐menopausal women. Although its etiology remains unclear, hormonal influences and a possible relationship with neurocognitive changes have been proposed.
Danielle Felsberg, Kira Morgan, Rickey‐Levon Burch, Madelyn Furr, Zachary Tyson, Steven Lesh   +5 more
wiley   +1 more source

Natural language processing to identify documented pain preceding radiation therapy for bone metastases. [PDF]

JNCI Cancer Spectr
Chen JJ, Feng J, Friesner ID, Chang C, Kenny C, Elia MV, Ni L, Feng FY, Rabow MW, Braunstein SE, Boreta LC, Hong JC.   +11 more
europepmc   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

British Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay, Amandine Manon, Hunter Stephens, S. Y. Amy Cheung, Bart de Keizer, Erik T. te Beek   +5 more
wiley   +1 more source

Microenvironmental and Molecular Pathways Driving Dormancy Escape in Bone Metastases. [PDF]

Int J Mol Sci
Bakir M, Dabaliz A, Dawalibi A, Mohammad KS.   +3 more
europepmc   +1 more source

A dose‐finding population pharmacokinetic/pharmacodynamic model of ginisortamab, an anti‐gremlin‐1 monoclonal antibody, in patients with solid tumours

British Journal of Clinical Pharmacology, EarlyView.
Aims Ginisortamab, a first‐in‐class human monoclonal antibody for the treatment of advanced solid tumours, binds to gremlin‐1 and restores bone morphogenetic protein signalling. We used pharmacokinetic/pharmacodynamic (PK/PD) modelling to characterize the relationship between ginisortamab dose and serum gremlin‐1 binding, using model‐based simulations ...
Yin Cheong Wong, Luisa Rojas Chavarro, Paul Jones, David Egging, Wanchana Ungphakorn, Marta Valle, Ivan Matthews   +6 more
wiley   +1 more source

Management of bone metastases in patients with breast cancer: review of bone-modifying therapy, emerging new agents, and future directions. [PDF]

Front Oncol
Bader G, Brown B, Davenport AP, Gatti-Mays M, Johnson KC, Lopetegui-Lia N, Quiroga D, Roy AM, Sardesai S, Stover D, Wesolowski R.   +10 more
europepmc   +1 more source

Mind the gap: Adherence to denosumab dosing and cessation guidelines in Australian residential aged care

British Journal of Clinical Pharmacology, EarlyView.
This original research used medication administration data to explore adherence to treatment guidelines for the most common osteoporosis medications in long‐term residential aged care (RAC) in Australia. The paper highlights gaps in adherence to treatment guidelines that must be addressed to improve outcomes of older adults living in RAC.
Marea O'Donnell, Johanna I. Westbrook, Bayzidur Rahman, Isabelle Meulenbroeks, Nasir Wabe, Ian D. Cameron, Mark Morgan, Magdalena Z. Raban   +7 more
wiley   +1 more source

Dacomitinib in Combination with chemotherapy is effective in lung adenocarcinoma with rare <i>EGFR</i> L747P mutation and bone metastases: a case report. [PDF]

Front Oncol
Su W, Deng H, Yang Z, Gao A, Gao B.
europepmc   +1 more source